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Abstract
Alzheimer’s disease (AD) is a slow, progressive neurodegenerative disease and the most
common type of dementia in the elderly. The etiology of AD and its underlying mechanism
are still not clear. In a previous study, we found that an ethyl acetate extract of Centipede-
grass (CG) (i.e., EA-CG) contained 4 types of Maysin derivatives, including Luteolin, Isoor-
ientin, Rhamnosylisoorientin, and Derhamnosylmaysin, and showed protective effects
against Amyloid beta (Aβ) by inhibiting oligomeric Aβ in cellular and in vitro models. Here,
we examined the preventative effects of EA-CG treatment on the Aβ burden in the Tg
(Mo/Hu APPswe PS1dE9) AD mouse model. We have investigated the EA-CG efficacy as
novel anti-AD likely preventing amyloid plaques using immunofluorescence staining to visu-
ally analyze Aβ40/42 and fibril formation with Thioflavin-S or 6E10 which are the profile of
immunoreactivity against epitope Aβ1–16 or neuritic plaque, the quantitation of humoral
immune response against Aβ, and the inflammatory cytokine responses (Th1 and Th2)
using ELISA and QRT-PCR. To minimize the toxicity of the extracted CG, we addressed the
liver toxicity in response to the CG extract treatment in Tg mice using relevant markers,
such as aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) measurements
in serum. The EA-CG extract significantly reduced the Aβ burden, the concentration of solu-
ble Aβ40/42 protein, and fibril formation in the hippocampus and cortex of the Tg mice
treated with EA-CG (50 mg/kg BW/day) for 6 months compared with the Tg mice treated
with a normal diet. Additionally, the profile of anti-inflammatory cytokines revealed that the
levels of Th2 (interleukin-4 (IL-4) and interleukin-10 (IL-10)) cytokines are more significantly
increased than Th1 (interferon-γ (IFN-γ), interleukin-2(IL-2)) in the sera. These results sug-
gest that the EA-CG fraction induces IL-4/IL-10-dependent anti-inflammatory cytokines
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(Th2) rather than pro-inflammatory cytokines (Th1), which are driven by IL-2/IFN-γ. With
regard to the immune response, EA-CG induced an immunoglobulin IgG and IgM response
against the EA-CG treatment in the Tg mice. Furthermore, EA-CG significantly ameliorated
the level of soluble Aβ42 and Aβ40. Similarly, we observed that the fibril formation was also
decreased by EA-CG treatment in the hippocampus and cortex after quantitative analysis
with Thioflavin-S staining in the Tg brain tissues. Taken together, our findings suggested
that Maysin and its derivative flavonoid compounds in the EA-CG fraction might be benefi-
cial therapeutic treatments or alternative preventative measures to adjuvant for boosting
humoral and cellular include immune response and anti-inflammation which may lead to
amyloid plaque accumulation in Alzheimer’s patients’ brains.
Introduction
Alzheimer’s disease (AD) is a complicated neuronal metabolic dysfunction disease that is asso-
ciated with the induction of inflammation due to microglia cell activation, a loss of synaptic
receptors, and neuronal cell loss, that leads to memory loss due to brain lesions. Amyloid pla-
ques are also present in AD, which consist of different toxic components of Aβ40 and Aβ42.
These toxic components reflect genetic alterations, including the β-amyloid precursor protein
(APP; Chromosome 21), the presenilin genes (PSEN1, chromosome 14; PSEN2, chromosome
1), Tau (Chromosome 17), apolipoprotein E (ApoE, Chromosome 19), and non-genetic alter-
ations. Non-genetic alterations include environmental factors, aging, hypertension, inflamma-
tion, diabetes, malfunction of lipid metabolism, psychological stress, bacterial and virus
infection and heavy-metal intoxication [1–7].
Oxidative stress is a key factor that disrupts the cellular defense machinery, which alters dif-
ferent types of transmembrane proteins (i.e., APP, NADPH oxidase) and increases metabolic
modulators (i.e., β-amyloid, glutamate, and [Ca2+]). This alteration results in the dysfunction
of synapses, autophagy, and proteasome activity. This triggers various pathological manifesta-
tions such as the formation of senile plaque, neuronal cell loss, mitochondrial dysfunction, and
inflammation with the activation of microglia in AD or dementia. Increasing lines of evidence
demonstrates that oxidative stress is associated with APP mutations, which result in the accu-
mulation of amyloid β-protein (Aβ), the major component of amyloid plaques. Oxidative
stress may be a causative factor that stimulates neuronal cell dysfunction in the development
of AD pathogenesis [8–10]. Environmental intoxication (i.e., contamination of food, air, and
water by metals or bacterial and viral infection), a non-genetic risk factor, may cause a prime
catalyst for metabolic or immune disruption. The causative toxic substances, which likely initi-
ate ROS or RNS production, disrupt the cellular defense system, such as the redox machinery
and immune surveillance, in AD. Notably, it has been reported that the mortality rate due to
infection has increased in elderly population suffering from Alzheimer’s disease [11].
Currently, the FDA approved few AD drugs, such as acetylcholinesterase inhibitors,
N-Methyl-D-aspartate (NMDA) receptor antagonists, monoclonal antibodies for anti-Aβ,
inhibitor for BACE, inhibitor for RAGE receptor and the combination drug of cromolyn
sodium and ibuprofen [12]. In the past few decades, various natural compounds (phytochemi-
cals and herbs), naturally occurring polyphenol (resveratrol, trans-3, 4’, 5-trihydroxystilbene),
and nutritional supplements (i.e., cinnamon extract and savory) with anti-oxidant and anti-
inflammatory activities have shown potential as a beneficial counteractive approach to prevent
Aβ neurotoxicity by inhibiting oligomeric formation, alternative counter measure of Tau
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malfunction as well as correcting memory impairment [13–16]. In previous studies, compel-
ling reports suggested that Centipedegrass (CG), which originates from China and South
America, contains C-glycosyl flavones and phenolic constituents as the biologically active
structural skeleton. Furthermore, it was reported that Maysin (a flavone C-glycoside from
corn silks and maize) and its precursor chemical components held antibiotic activity that is
likely to inhibit the growth of the fall armyworm larva [17] and to resist ear damage by the
corn earworm [18]. Also, it was suggested that total phenolic content of silk extracts that con-
tain flavonoids, such as Maysin inhibited non-enzymatic glycation and the formation of
advanced glycation end products (AGEs), as well as having anti-fungal effects [19]. Moreover,
we explored the potential anti-Alzheimer’s effect of a CG extract, in which Maysin and its
derivatives could exert protective effects for neurons by inhibiting oligomeric Aβ42 aggrega-
tion and β-Secretase (BACE) and decreasing neuronal toxicity by using neuronal PC12 cells as
an in vitro model [20]. BACE, a potential drug candidate was examined its functional advan-
tage for early phase preclinical familial AD patients along with inhibitor of RAGE (advanced
glycation end products) in a Phase III clinical development stage [12]. In this study, our find-
ings indicate that the natural Maysin and its derivative flavonoid compounds in EA-CG extract
significantly prevented AD pathogenesis. It also demonstrated reduction of soluble Aβ burden
in brain and mitigates formation of amyloid plaques outside the neurons by enhancing the
immune response associated with Th2-skewed cytokine response in an APP/PS1 Tg Alzhei-
mer’s disease mouse model.
Materials and Methods
Maysin and its flavonoid derivative compounds from
Centipedegrass (CG)
Isolation, Purification and yield of Maysin and its derivative from Centipedegrass (CG) were
described by Song et al. in-detail as previously [20].
Animals
The animals were treated and maintained in accordance with the Animal Care and Use Guide-
lines of Gyeongsang National University, South Korea. All experimental protocols were
approved through the Institutional Animal Care and Use Committee of Gyeongsang National
University (approval number; GNU-130315-M0025). The B6C3-Tg (APPswe, PSEN1dE9)
85Dbo/J strain of AD mice was obtained from Jackson Laboratory (Bar Harbor, Maine, USA).
All animal were housed in each cage under a 12 h light/dark cycle (light on 07:30 AM-19:30
PM) at a constant temperature (23 ± 1˚C) and relative humidity (60 ± 10%) and were provided
food and water ad libitum. All mice were allowed free access to their respective diets and
drinking water for six months. Two groups of mice (n = 10 mice, 10 males per group, 10 week
old mice) were treated for six months before being sacrificed. The mice in the first group were
fed a control diet and administered PBS. The Tg mice in the second group were administered
EA-CG (50 mg/kg BW) daily. We were not able to measure the food intake for individual mice
because the food was provided in a common tray. Mice were food deprived overnight prior to
blood collection and euthanized by ketamine (40 mg/kg) plus xylazine (2 mg/kg).
Toxicology study using biochemical analysis
The biochemical analyses were performed using commercial kits (Asan Pharmaceutical, Co.,
Korea). Blood was collected 12 h after the last EA-CG administration. After collect sera from
each of EA-CG treated Tg mice by centrifugation at 10,000 x g for 10 min following overnight
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incubation, the levels of aspartate aminotransferase (AST) and alanine aminotransferase
(ALT) in the sera were detected with a DRI-CHEM analyzer (Fujifilm, Japan), respectively.
The quantitative data was presented with Unit/L.
Quantification of anti-Aβ immunoglobulins and cytokines by Enzyme-
linked immunosorbent assay
Blood was collected from each group of EA-CG treated Tg and /or control Tg. After incubat-
ing blood at 4˚C for 30 min, the blood was centrifuged at 10,000 g for 10 min, and then, serum
was collected and stored at -80˚C until it was used. The anti-Aβ immunoglobulins (IgG and
IgM) in mouse serum were also measured by Enzyme-linked immunosorbent assay (ELISA),
according to the manufacturer’s protocol, as previously described by Kim et al. [21]. Briefly,
Microtiter immuno plate (Nunc, 8 well flat bottom; Rochester, NY) were coated with peptide
Aβ 1–42 (5 μg/ml) in 50 mM carbonate buffer pH 9.6 overnight at 4˚C and rinsed three times
with washing buffer [phosphate-buffered saline (PBS) containing 0.05% Tween-20]. Microtiter
immuno plate were treated with blocking buffer (5.0% goat serum, 1% BSA and 0.05% Tween-
20 in PBS) for 1 h at room temperature (25~27˚C). The serum samples were diluted with PBS
and added to each wells in Microtiter immuno plate. After incubation for 2 h at room tempera-
ture with shaking gently, the plates were washed five times with the washing buffer and incu-
bated for 1 h with an appropriate horseradish peroxidase (HRP)-conjugated detection
antibody. The detection antibodies (Zymed, CA) were diluted in the blocking buffer at 1:2000
for anti-mouse IgG and IgM. After washing, plates were incubated with Chromogenic sub-
strate (3,30,5,50-tetramethylbenzidine, TMB) (Pierce Biotechnology, IL USA) for 15~30 min
and the reaction was stopped with the addition of 1N H2SO4. The optical densities at 450–
550 nm were analyzed using a microreader (Versa max, Molecular Devices, CA) and linear
regression was confirmed by 6E10, monoclonal anti-Aβ antibody, as positive internal control.
It means the concentrations (μg/ml) of the serum titers presented here reflect the concentra-
tions of 6E10 antibody. Comparison of treatment groups was performed by ANOVA and two-
tailed Student’s t-test. P < 0.05 indicates statistically significant.
Quantification of cytokines using Enzyme-linked immunosorbent assay
T cell specific cytokines (i.e., Interferon-γ (IFN-γ), interleukin (IL)-2, IL-4, and IL-10) in
mouse serum were also measured by Enzyme-linked immunosorbent assay (ELISA) using
1x TMB as a chromogenic substrate, according to the manufacturer’s protocol (eBiosciecne,
San Diego, CA). Optic densities at 450 nm were determined using a microreader (Versa max,
Molecular Devices, CA) within the linear regression. Each sample was measured in triplicates.
The minimum detectable concentrations were 2 pg/ml for IL-2, 15.6 pg/ml for IFN-γ, 4 pg/ml
for IL-4, and 32 pg/ml for IL-10.
Quantification of soluble Aβ40 and Aβ42 by Enzyme-linked
immunosorbent assay
For quantitation purposes, we used a highly specific and a sensitive sandwich enzyme-linked
immunosorbent assay (ELISA) which was performed as described previously by Kim et al. [22]
with some modifications First, we quantified insoluble Aβ40 and Aβ42 in the brain homoge-
nates extracted with TBS (50 mM Tris-HCl, pH 7.6, 150 mM NaCl) or 2% SDS and 70% formic
acid, respectively, as previously described [21]. A frozen hemisphere of the brain tissue was
homogenized with a homogenizer in 1 ml of TBS/complete protease inhibitors (Roche, Mann-
heim, Germany), and then centrifuged at 100,000 g for 1 h at 4˚C using an Optima TLX
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ultracentrifuge (Beckman Coulter Inc., CA). The TBS supernatants were stored at -80˚C and
the pellets were homogenized in 1 ml of 2% SDS/TBS with protease inhibitors (Roche), and
then centrifuged at 100,000 g for 1 h at 25˚C following 15 min incubation at 37˚C. The pellets
(corresponding to the insoluble fraction) were washed once, extracted further with 1 ml of
70% formic acid, and then centrifuged at 100,000 g for 1 h. The supernatants from the insolu-
ble 70% formic acid extracts were neutralized with 1 M Tris-HCl, pH 8.0 at a dilution of 1:20.
Then, the buffer soluble whole brain samples include neocortex and hippocampus was ana-
lyzed for Aβ levels using an ELISA kit (Invitrogen Corporation, Carlsbad, CA), according to
the manufacturer’s instructions. The supernatant was diluted with a standard dilution buffer
at 1:2000 (Aβ40) or 1:400 (Aβ42) and measured according to the manufacturer’s instructions.
The obtained values were corrected for the wet weight of each brain sample and expressed
as μg/mg brain.
Detection of Aβ plaque by immunohistochemistry and Aβ fibrils burden
with Thioflavin-S staining
The mice were deeply anesthetized with sodium pentobarbital and cardinally perfused with
0.9% chilled saline followed by 4% chilled formaldehyde in 0.1 M phosphate buffer (pH 7.4).
The mouse brains were quickly removed and fixed in 4% paraformaldehyde for 24 h at 4˚C.
The brains were post-fixed overnight in 30% sucrose in 0.1M PBS. For preparing coronal
mouse brain from APP/PS1 mice, brain section (35 μm thick) were cut include interested
areas such as the cortex and hippocampus a freezing-stage cytochrome and kept them 0.1M
PBS at 4˚C. Sections were further processed for immunohistochemistry. Briefly, for detection
Aβ42 and Aβ40 protein in the brain, immunohistochemistry was performed. First, elimination
of endogenous peroxidase was performed by treatment of 1% H2O2/10% methanol in Tris-
buffered saline (TBS) for 30 min at room temperature (RT). After washing section with 0.1M
Tris-buffer (pH 7.4), sections blocked with 5% fetal bovine serum in 0.1M TBS with 0.5% tri-
ton-X 100 (TRB-T) for 1h at RT to reduce non-specific protein binding. Then, sections were
incubated with primary antibody such as a mouse anti-Aβ antibody (6E10, Mouse Monoclonal
antibody) (1:200; Covance, San Diego, CA) in TBS-T for overnight at 4˚C. The sections were
rinsed in 0.1M TBS containing with 1% serum and incubated with fluorescence conjugated
second antibody for 30 min at room temperature. The secondary antibody used for fluores-
cence microscopy was Alexa Fluor 488-conjugated anti-mouse IgG (1:200, Invitrogen, Cama-
rillo, CA). The section was coverslip with prolong gold anti-fade mountant (life technologies,
Carlsbad, CA) and capture image under a confocal microscope. Those section were also per-
formed counter staining with Hematoxylin and eosin (H&E) staining using brain collected
from Mo/Hu APPswe PS1dE9 mice control (n = 3) and treated with EA-CG (n = 6) for safety
evaluation in histological views. Four left hemisphere sections of brain including those from
the cerebrum, and hippocampus were presented on each slide after two slides from each
mouse were examined. Using paraffin embedded sections, first conduct de-paraffinized the
section and washing them standard protocol as followings: xylene for 10 min, washing sections
for 5 min in a serial dilution alcohol (from 95% to 50%), then washing sections for 10 min with
double distilled water, and three times at 5 min each with phosphate-buffered saline (PBS,
pH7.4). The brain sections (10 micron) were also treated with 1% Thioflavin-S (Sigma Aldrich,
St Louis, MO) followed by destaining in 70% ethanol to detect the Aβ fibrils in hippocampus
and cortex. Morphometric analysis using histology samples (1% Thioflavin-S stained samples)
for quantification of amyloid fiber in hippocampus and cortex area, stained area was captured
and then, performed quantitative analysis using Olympus BX61 automated microscope, Olym-
pus fluoview system and the image pro plus v4 image analysis software (Media cybernetics,
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silver spring MD) which could capable of color segmentation and automation via programma-
ble macros. Using coronal brain sections (n = 4), each section was separated by approximately
consecutive 300 μm interval from each mouse were analyzed with each staining method at
approximately forty fields (1 mm2 per each, using a 10X objective and a 1X eyepiece lens).
Amyloid burden was expressed as a percentage of total area covered in hippocampus or neo-
cortex by Thioflavine-S fluorescence, separately. Data were presented as mean ± standard
error in a bar graph.
Semi-quantitative RT-qPCR
The hepatic tissue or brain tissue was isolated and soaked in RNAlater1 Tissue Collection:
RNA, Stabilization Solution (Ambion, Austin, TX) at 4˚C overnight and then moved to -80˚C.
These tissues were homogenized in TRIzol reagent (Invitrogen, CA) to isolate the RNA. The
RNA samples were treated with RNase-free DNase (Qiagen, Valencia, CA) for 15 min at room
temperature, and the total RNA was purified using QIAGEN RNeasy columns. The comple-
mentary DNA (cDNA) was generated from 2 μg of the total RNA in a total volume of 20 μl
using the SuperScript1 III First-Strand Synthesis Kit (Invitrogen) according to the manufac-
turer’s protocol. The target cDNA was amplified using fluorescent SYBR dye and specific prim-
ers as followings: For Pro-inflammatory marker in hepatic tissue, interleukin (IL)-1α, forward
5’-AGGAGAGCCGGGTGACAGTA-30 and reverse 50-AACTCAGCCGTCTCTTCTTCAGA-30;
IFN-γ, forward 5’-TGAACGCTACACACTGCATCTTG-3’ and reverse 5’- GTTATTCAGA
CTTTCTAGGCTTTCAATG-3’;β-actin (control), forward 5'-GACAACGGCTCCGGCATGTG
CAAAG-3' and reverse 5’-TTCACGGTTGGCCTTAGGGTTCAG-3’; for Pro-inflammatory
marker Brain tissue, TNF-α forward 5’-TCTTCTCGAACCCCGAGTGA-3’ and reverse 5’-
CCTCTGATGGCACCACCAG-3’; IL-1β forward 5’-AGGTGCTCATGTCCTCATCC-3’ and
reverse 5’-CAGGCAGGCAGTATCACTCA-3’; GAPDH forward 5’-GTCATCATCTCTGCC
CCCTCTGCTG-3’ and reverse 5’-CGACGCCTGCTTCACCACCTTCTTG-3’. The PCR prod-
ucts were also confirmed after separate follow by electrophoresis on a 1.5% agarose gel for
30 min at 100 V. The gels were stained with 1 mg/ml Ethidium bromide and visualized with
UV light using the Bio-Rad Gel Doc image analysis software (Bio-Rad Laboratories Inc., CA,
USA). Gene expression was normalized to β-actin as a reference gene. Quantified mRNA of
each interested gene was normalized to β-actin mRNA level (ΔCt) and relative to the appropri-
ate internal control (ΔΔCt) expressed as fold induction or decrease of control. The data were
analyzed using CFX 96 real-time PCR instrument according to manufacturer’s software man-
ual (BioRad, Hercules, CA, USA).
Statistical analysis
The data are expressed as the means ± S.E.M. The significant differences between the EA-CG-
treated and control (PBS) Tg mice were performed by Sigma Plot software (San Jose, CA,
USA) using analysis of variance (ANOVA) and two-tailed Student’s t-test. A value of p< 0.05
was considered statistically significant; n.s. mean not significant.
Results
CG extract (EA-CG fraction) induces an immune response in APP/PS1
transgenic (Tg) mice
To test the efficacy of natural flavonoid compounds, we have isolated Maysin and its derivative
flavonoid compounds by HPLC and gel filtration followed by elution with ethyl acetate soluble
fraction (the so-called EA-CG fraction) from Centipedegrass (CG). In the biochemical analysis
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profile, it appeared that Maysin might be the major chemical component in the EA-CG frac-
tion isolated from CG. Briefly, the isolated crude solvent extract of CG was further purified by
analytic high-performance liquid column chromatography and size-dependent chromatogra-
phy such as the gel filtration method. After quantification of each of the five chemical compo-
nents, including Maysin and its derivative flavonoid compounds in the EA-CG fraction (for
example, Luteolin, Isoorientin, Rhamnosylisoorientin, Derhamnosylmaysin, and Maysin),
their production weight per 100 mg extracts was determined as the purification yield from
each batch, as described in detail in a previous report [20]. Fig 1 show it has delineated a series
of studies in the exploration of anti-AD lead compounds like Maysin, and its derivative flavo-
noid among medicine alternatives of pre-screened natural herb, CG, are designed and con-
ducted following designated treatment protocol and sampling. This is to determine the effect
of immune modulation of CG flavonoid compounds on prevention and/or prophylactic effi-
cacy against amyloid plaque/fibril formation due to genetic factors while following relevant
assessment strategies such as biochemical, immunological, patho-histological in the B6C3 Tg
(APPswe and PSEN1sE9) 85 Dbo/J as an animal model for AD.
To determine whether natural flavonoid compounds such as Maysin and its precursor
chemicals (labeled as EA-CG fraction) induce a humoral immune response, we have measured
the IgG or IgM antibody production as a representative indicator of the immune response
using an enzyme-linked immunosorbent assay (ELISA). Briefly, after dividing the mice into
two groups, we fed the APP/PS1 mice (10-weeks old, all male mice) the EA-CG fraction,
which contains Maysin and its precursor chemicals, in a mixture with the normal diet
Fig 1. Assessment workflow of novel Anti-AD effectiveness using Maysin and its flavonoid derivative
compounds on APP/PS1 AD mice model. Complication of traumatic brain injury is associated with inflammation
and neural cell death from induction of Aβ 42/40 formation likely due to unfolded cerebral plaque or fibril form which
results from genetic alteration in APPswe and PSEN1dE9 in the 85Dbo/J mice model for Experimental AD study.
Experimental design for treatment and sampling procedure as the objectives in animal model to understand anti-AD
of Maysin flavonoid with respect to prevention and/or prophylactic effect against Aβ40/42 mediated neuronal-toxicity
and functional delineation as the assessment workflow in animal study are presented.
doi:10.1371/journal.pone.0169509.g001
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(50 mg/kg BW, n = 10 mice) and the control Tg mice (n = 10 mice) were fed with the normal
diet for 6 months. Six months later, the sera were isolated from the mouse blood by centrifuga-
tion, and the IgG and IgM levels were determined to identify the immune response against the
Aβ1–42 peptide using an HRP-conjugated secondary antibody specific for mouse IgG or IgM,
respectively. As shown in Fig 2A, the immune response of the EA-CG-fed mice increased to
4.5 ± 0.35 μg/ml IgG in the sera, while the normal diet-fed mice produced 2.7 ± 0.26 μg/ml
IgG (p = 0.031, IgG response, 1.67-fold induction compared to the control (PBS)). Interest-
ingly, the immune response of IgM in the sera also increased to 2.3 ± 0.27 μg/ml in the
EA-CG-fed mice compared with 1.7 ± 0.19 μg/ml in the control normal diet-fed mice
(p = 0.041, IgM response, 1.35-fold induction) (Fig 2B). The difference between the control
IgM and EA-CG treated IgM levels was significant (p< 0.05 to control IgM vs EA-CG
Treated IgM). These results indicate that Maysin and its precursor chemical components in
the EA-CG fraction can trigger a humoral immune response by inducing an IgG antibody
response. In addition, we also observed a slight induction in the IgM immune response after
six months of feeding with natural flavonoid compounds utilize EA-CG extracts in the APP/
PS1 Tg mice. This suggests that the induction of IgG and IgM isotypes with natural Maysin fla-
vonoid compounds (Maysin and its derivatives in CG) may play a role in the humoral immune
response using APP/PS1 Tg AD mouse model with six months’ treatment as a feeding
timeline.
Natural Maysin flavonoid compounds in the EA-CG fraction has no
harmful hepatic effects
To clarify the effect of the solvent-extracted natural bioactive compounds on histopathological
damage in the EA-CG-treated APP/PS1 Tg experimental animals, we first examined the
hepatic toxicity using two different assays: an enzymatic assay of the tissue transaminases
(ALT and AST) and a gene expression profile using RT-PCR for representative markers of
pro-inflammatory cytokines (i.e., IL-1α and IFN-γ). First, we measured if EA-CG compounds
Fig 2. Effect of Centipedegrass (CG) extract on humoral immune response in APP/PS1 transgenic
(Tg) mice. The CG ethylacetate (EA-CG) fraction contains five flavoglycosides, including Maysin and other
phytochemicals, as described in a previous study [20]. Mouse sera were isolated from the EA-CG-treated and
control Tg animal subjects (Mo/Hu APPswe PS1dE9) after feeding with admixture in diet food for 6 months
(n = 10 mice per each group; all male and 10 weeks old mice). (A, B) To measure the beta amyloid dependent
antibody response, using a sandwich ELISA, quantitation was performed utilize the Aβ1–42 synthetic peptide
as the coating antigen and HRP-conjugated secondary IgG or IgM as a secondary antibody. Immunoglobulin
IgG (A) and Immunoglobulin IgM (B), markers of an immune response against the EA-CG extract, were
measured by ELISA, which was described in detail in the Materials and Methods. The values were presented
as the means ± S.E.M. *p < 0.05 means statistically significant.
doi:10.1371/journal.pone.0169509.g002
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may insult on hepatocellular damage in the serum levels with respect to ALT and AST trans-
aminases in EA-CG-fed and vehicle-treated (PBS) Tg mice using an enzymatic ALT/ALS assay
kit, according to the manufacturer’s instruction.
Consequently, we also analyzed the alterations in the inflammatory response using tissue
specimens from the EA-CG-treated and control (vehicle-treated) APP/PS1 Tg mice. After per-
forming the RT-qPCR with specific primers to the amplify genes as described in materials and
methods, we analyzed the mRNA level of pro-inflammatory cytokines (i.e., IL-1α and IFN-γ)
using total RNA in hepatic tissue from the EA-CG-treated and control (PBS)-treated Tg mice
and presented the fold change in the gene expression after normalization with the housekeep-
ing gene. As shown in Fig 3, we observed that the level of ALT and AST in the serum was simi-
lar in the Tg mice that were fed a normal diet and the Tg mice fed with EA-CG (Fig 3C and
Fig 3. Effect of CG extracts on liver toxicity using aspartate/alanine aminotransferase activity in Tg
mice. The Mo/Hu APPswe PS1dE9 mice were fed with or without EA-CG (50 mg/kg BW) for 6 months. The
brain were isolated from the EA-CG treated and control (PBS) groups (n = 3 mice per each group). After the
brain was divided in half, we tested the gene expression profile of the inflammatory cytokines IL-1α (A) and
IFN-γ (B) as markers of the cellular response by semi-quantitative RT-PCR. The fold change was presented
after normalization to the housekeeping gene β-actin). *p < 0.05; n.s. mean not significant. The levels of
Aspartate aminotransferase activity (AST, Units/L) and Alanine aminotransferase activity (ALT, Units/L)) were
measured in the sera by centrifugation after obtain mice blood from each group, and then the relative value
(U/L) of ALT (C) or AST (D) as hepatotoxicity markers were measured and presented after comparison to the
controls (PBS groups), according to the manufacturer’s instructions. The values were presented as the
means ± S.E.M (n = 3 mice per each group). n.s. mean not significant.
doi:10.1371/journal.pone.0169509.g003
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3D). In another experiment with relevant biomarker gene expression, we observed that the
EA-CG fraction induced the expression of pro-inflammatory cytokine mRNAs, including IL-
1α (2.3- vs. 3.0-fold change; control (PBS) Tg mice vs. EA-CG-fed Tg mice, n.s; p = 0.0589)
and IFN-γ (2.7- vs. 4.0-fold change; control (PBS) Tg mice vs. EA-CG-fed Tg mice, p< 0.05).
The results from the gene expression profile suggest that Maysin and other phytochemical
components in the EA-CG fraction slightly triggered the pro-inflammatory cytokine IFN-γ as
a skewed T cell response (Fig 3B). In contrary induction of IFN-γ mRNA expression compared
to control (Tg alone), the IL-1α mRNA expression not significantly increased after normaliza-
tion with the β-actin housekeeping gene (Fig 3A). Although the EA-CG fraction may cause an
IFN-γ-dependent pro-inflammatory response in liver tissue, there is no significant change in
IL-2 with regard to organ injury, based on the hepatic tissue (data not shown).
Natural Maysin flavonoid compounds in the EA-CG fraction induces a
Th2-skewed cytokine response
To determine whether the EA-CG fraction from CG may induce T-cell activation, most likely
T lymphocyte helper (Th) 1 or Th2 cytokine responses, we quantified the secreted Th1 (pro-
inflammatory) or Th2 (Anti-inflammatory) profiles using a cytokine ELISA assay and sera
from the EA-CG-treated and control Tg mice. The cytokine response was shown in Fig 4.
The Th2 cytokine profile (Fig 4B and 4C) included the IL-4 serum levels (220 ± 21.0 vs.
390 ± 40.0 pg/ml; control (PBS) Tg mice vs. EA-CG-treated Tg mice) (P = 0.045) and IL-10
serum levels (950 ± 80.4 vs. 1150 ± 110.6 pg/ml; control (PBS) Tg mice vs. EA-CG-treated Tg
mice) (P = 0.036); the Th1 cytokines (Fig 4A and 4D) included the IL-2 serum levels (62 ± 2.5
vs. 70 ± 4.0 pg/ml; control (PBS) Tg mice vs. EA-CG-treated Tg mice) (P = 0.0568) and IFN-γ
serum levels (7.2 ± 0.8 vs. 10 ± 0.9 pg/ml; control (PBS) Tg mice vs. EA-CG-treated Tg mice)
(P = 0.061). Based on the quantifying the Th1 and Th2 cytokines levels, we hypothesized that
the EA-CG extract may exert its efficacy in preventing AD by promoting significantly the Th2
cytokine response rather than the Th1 response in APP/PS1 Tg mice after six months of feed-
ing with Maysin and its derivatives.
To define further analysis with regard to inflammation and neuroprotection aspects, we
measured the difference mRNA cytokines expression using relevant gene markers (i.e., TNF-α
and IL-1β) between control Tg mice and EA-CG-treated Tg mice using RT-qPCR. There is no
significant difference in gene expression profile represented by fold change after normalized
with GAPDH as followings: for example, expressions of TNF-α mRNA, control Tg mice and
EA-CG-treated Tg mice (1.0 ± 0.2 vs. 0.89 ± 0.09, P = 0.0623) and for IL-1β, control Tg mice
and EA-CG-treated Tg mice (1.0 ± 0.14 vs. 1.35 ± 0.23, P = 0.0581). Taken together, these
result indicated that the EA-CG extract containing Maysin and its derivative flavonoid com-
pounds could exert in preventing or ameliorating amyloid aggregation by enhancing Th2 cyto-
kine production without coincidence event likely to activate pro-inflammatory T cell
signaling.
Amyloid plaques are reduced in Maysin flavonoid compounds treated
APP/PS1 Tg mouse brains
The amyloid plaque burden is a key pathological phenomenon in Alzheimer’s disease that
accelerates neuronal damage and impairs cognition. We have evaluated the differences in the
amyloid plaque burden include diffuse and fibrillary amyloid deposit in the brains of the
EA-CG-treated and control Tg mice by using immunofluorescence staining with the specific
antibody 6E10. Antibody 6E10 is a monoclonal antibody that was generated against the Aβ1–
16 epitope. Representative image was shown in Fig 5A, we also observed mitigation of amyloid
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Fig 4. Comparison cytokine profile between Th1 and Th2 CG in the Tg brains by the CG extracts. The
T cell-mediated inflammatory response, including Th1 (IL-2 and IFN-γ) (A, D) and Th2 (IL-4 and IL-10) (B, C)
cytokines, was measured by a cytokine ELISA using the EA-CG-treated Tg (Mo/Hu APPswe PS1dE9) mice
compared to the control (PBS) treated Tg mice. After the mice sera were isolated by centrifugation, the levels
of the pro-inflammatory cytokines (Th1: IL-2 and IFN-γ) and anti-inflammatory cytokines (Th2: IL-4 and IL-10)
were quantitated and analyzed the difference sera between in the EA-CG-treated and vehicle (PBS)-treated
control Tg (Mo/Hu APPswe PS1dE9) mice. For quantifying pro-inflammation difference between control Tg
and Tg+EA-CG in gene expression profile, gene of interest (TNF-α (E) and IL-1β(F)) was presented as
relative fold change after normalized with housekeeping gene (GAPDH). The values were presented as the
means ± S.E.M (n = 10 mice per each group). *p < 0.05. Tg vs. Tg+EA-CG; n.s. mean not significant.
doi:10.1371/journal.pone.0169509.g004
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burden in the APP/PS1 Tg mice in both the hippocampus (Average of percentage of Area as
Aβ load: 1.704 ± 0.209 vs. 0.287± 0.081 in Tg vs Tg+EA-CG, P< 0.0023) (Fig 5B) and cortex
(Average of percentage of Area as Aβ load: 2.189 ± 0.189 vs. 1.025 ± 0.068 in Tg vs Tg+EA-CG,
P< 0.001) (Fig 5C) was significantly reduced in the EA-CG-treated (50 mg/Kg BW) Tg mice
group compared to the control Tg mice that were fed a normal diet. To monitor the patho-
histological relevance, each brain section, including the hippocampus and cortex, was counter-
stained with Hematoxylin and Eosin (H&E). These histological results indicated that EA-CG
prevented amyloid plaques include diffuse and fibrillar Aβ deposits in both the hippocampus
and cortex in the APP/PS1 Tg mice.
Amyloid fibril burden are decreased by Maysin flavonoid compounds
treated APP/PS1 Tg mice
To further determine whether the EA-CG fraction reduced amyloid fibril formation, we exam-
ined the brain morphology by staining utilize Thioflavin-S, which specifically binds the amy-
loid fibrils at hippocampal and cortical lesions. By comparing the EA-CG-treated or vehicle
(PBS)-treated Tg mice, we observed that the EA-CG fraction reduced the amyloid fibril burden
by 47.27% in the hippocampus (1.1 ± 0.23 in the control (PBS)-treated Tg mice vs. 0.58 ± 0.08
in the EA-CG-treated Tg mice, P < 0.021) and 44.0% in the cortex (1.25 ± 0.31 in the control
(PBS)-treated Tg mice vs. 0.7 ± 0.09 in the EA-CG-treated Tg mice, P < 0.036). The quantita-
tive results of the amyloid fibrils from representative images were shown in Fig 5D (hippocam-
pus) and 5E (cortex), respectively. These results suggest that Maysin and its derivatives
flavonoid compounds in the EA-CG fraction significantly prevented amyloid plaques as well
as fibril formation, the key features of AD, in both the hippocampus and cortex of the
APP/PS1 Tg Alzheimer’ disease mouse model.
The cerebral Aβ load is reduced by Maysin and its derivative flavonoid
compounds
As shown in previous studies, the Aβ load is associated with neurotic plaques in the cerebral
cortex. To determine the effect of Maysin and its derivative flavonoid compounds on the Aβ
load, the total amounts of 42 and Aβ40 in the hippocampus and cortex areas on Tg brains
were analyzed using Aβ42 or Aβ40 ELISA kits. As shown in Fig 6, the average Aβ42 concentra-
tion in the EA-CG-treated Tg mice was 0.80 ± 0.1 μg/mg protein. Meanwhile, the average
Aβ42 concentration in the control Tg mice treated with a normal diet was 2.71 ± 0.26 μg/mg
(P< 0.0012) (Fig 6A). Similarly, the average Aβ40 concentration in EA-CG-treated Tg mice
was 0.41 ± 0.09 μg/mg protein compared to control Tg mice treated with a normal diet
(1.26 ± 0.13 μg/mg protein) (P< 0.0016) (Fig 6B). These results suggested that the burden of
cerebral amyloid load (i.e., hippocampus and neocortex) could be altered in the Tg mice fol-
lowing treatment with Maysin and its derivative flavonoid compounds, based on the reduction
in the Aβ42 and Aβ40 levels in the APP/PS1 Tg brains after 6 months of treatment.
Discussion
Alzheimer disease (AD) is a complex and common progressive neurodegenerative disease that
reflects multifactorial gene mutation (i.e., APP, Presenilin (PSEN) 1 and PSEN 2, ApoE4) as a
hallmark of the etiology of familial AD (FAD) and Sporadic AD (SAD) in the elderly popula-
tion [23–25]. While a substantial proportion of the vulnerability for APP in AD may be
accounted for by genetic factors, environmental factors include oxidative stress, mitochondrial
dysfunction, and inflammation probably play a significant role [26–30]. It was also projected
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Fig 5. Comparison of the amyloid burden in the Tg brains by the CG extracts. (A) The amyloid plaques
were identified by immunohistochemistry (IH) and H&E counterstaining. The CG extract-treated (EA-CG
fraction) and control Tg brain sections were formalin fixed and subjected to immunohistochemistry with the
6E10 antibody that interacts with the Aβ1–16 epitope (monoclonal antibody) in the hippocampus (a, control; b,
EA-CG treated) and cortex (e, control; f, EA-CG-treated). Concomitant with the IH staining, other
hippocampal (n = 6) (c, vehicle; d, EA-CG-treated) and cortical (n = 6) (g, vehicle; h, EA-CG-treated) sections
from the Mo/Hu APPswe PS1dE9 mice were subjected to H&E counterstaining. The scale bar indicates
200 μm (a through h). The amyloid load (% of stained area) as a quantitation result was decreased by the CG
extracts (B. hippocampus area; C. cortex area). The area in the hippocampus (D, vehicle alone vs. EA-CG)
and cortex (E, vehicle alone vs. EA-CG) was quantified by comparing the morphometric analysis of the
Thioflavin-S-stained area between the vehicle-treated vs. EA-CG-treated Mo/Hu APPswe PS1dE9 brain
sections. The values (%) shown were the means ± S.E.M. *p < 0.05, Tg vs. Tg+EA-CG.
doi:10.1371/journal.pone.0169509.g005
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the genetic cause of Alzheimer disease (AD) is understood for less than 1% gene mutations
(APP, PS1, PS2) in early onset FAD or 20% (APOE4 allele) in late onset FAD cases, respec-
tively [31]. For the remainder of AD sufferers, multiple genetic and environmental factors
probably play a role in contributing to disease onset, severity and progression due to promo-
tion of amyloid-beta peptide (Aβ42/40) generation following proceeding of APP cleavage due
to secretase activation [32–34]. To date, there is no cure for AD and therapeutic measures are
being actively explored through small molecule likely inhibitors to three isoform of secretases
and/or neutralization of amyloid-beta peptide (Aβ42/40) toxicity using biologicals, small mole-
cules, and immunotherapy in the pharmacological active natural compounds.
It was reported the potentiality as therapeutic regimen in which anti-AD-like effectiveness
of the natural flavonoid compounds in CG extract (EA-CG) in a Mo/Hu APPswe PS1dE9 Tg
AD mouse model. The natural flavonoid compounds, named the EA-CG extract, which con-
tained five phytochemicals that are the major constituents of Maysin (i.e., Luteolin, Isoorien-
tin, Rhamnosylisoorientin, Derhamnosylmaysin, and Maysin) in which those are may
represents a potential anti-BACE1 phytochemicals as non-pharmacological alternatives or diet
regimen that could prevent AD-like pathological symptoms by reducing soluble β-amyloid
production and inhibiting amyloid plaque formation [20]. Compelling evidence support the
premise likely effectiveness of natural flavonoids as Anti-AD in which one of flavonoid com-
pound, Luteolin (include c-glycosylated derivatives) or Isoorientin, have shown its efficacy to
prevent anti-Diabetic, anti-diabetic using diet induce cognitive deficit in obesity C57Bl/6 mice
[35, 20] Liu et al. reported that Luteolin exerted anti-AD effect such as impairment of spatial
learning and memory capabilities, dysfunction of microvascular function, the intervene
regional cerebral blood flow, result from Aβ (25–35) derived production of reactive oxygen
species (ROS) using i.c.v. injection of aggregated Aβ (25–35) peptide in Male Kunming mice
[36]. They explicated therapeutic efficacy of Luteolin as Anti-AD rely on the activation of cho-
linergic neuronal network with boosting brain-derived neurotrophic factor (BDNF) through
its receptor tyrosine kinase B expression located in cerebral cortex [36]. Similarly, the impact
of Luteolin on neuroprotection led by Cheng et al. was demonstrated that flavonoid
Fig 6. Comparison of Soluble Aβ42/40 by the CG extracts on Tg mice brain. The cerebral Aβ42(A) and
Aβ40 (B) load was quantitated by capturing antigen such as Amyloid beta 42 and/or Amyloid beta 40
mediated Enzyme-Linked Immunosorbent Assay (ELISA) kit (Invitrogen, CA) using brain lysates (i.e., total
brain lysate of hippocampus and neocortex area) from the EA-CG-treated or vehicle (PBS)-treated Tg (Mo/Hu
APPswe PS1dE9) mice. The cerebral Aβ42 concentrations in the EA-CG-treated mice were significantly
reduced compared to the vehicle-treated controls (**P < 0.01). The values shown were the means ± S.E.M.
(n = 10 per group).
doi:10.1371/journal.pone.0169509.g006
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compound likely Luteolin prevent signaling intervention reflects Aβ (25–35) induced neuronal
cell death result from alteration of signaling molecules pertaining to oxidative stress such as
ERK-p, JNK, JNK-p, P38-p and caspase 3 activations using rat primary cortical cultures [37].
Alzheimer’s disease (AD) is also known as featured pathology likely amyloid aggregates that
result from oxidative stress and inflammation due to multifactorial oxidative reactions, includ-
ing protein oxidation, lipid peroxidation, and ROS generation. These reactions potentially
exacerbate neuro-inflammation and neuronal cell damage and may lead to neurodegeneration
[38].
Similar to previous reports, it was indicated the molecular target causes multifactorial brain
dysfunction as a consequence of oxidative damage, resulting in inflammation, calcium homeo-
stasis disturbance, and an imbalance of the redox system in AD. Oxidative stress is profoundly
associated with several metabolic disruptions in AD patients, such as mitochondrial dysfunc-
tion and altered activity of mitochondrial cytochrome oxidase, pyruvate dehydrogenase, and
α-ketodehydrogenase [39]. Other metabolic disruptions could be associated with oxidative
stress in which synaptic dysfunction induced by Aβ is internalized within membrane recep-
tors, such as NMDA, advanced glycation of end-product receptors and/or alpha 7 nicotinic
acetylcholine receptors [40].
The accumulation of toxic, soluble Aβ40/42 in the brain sequentially induces oxidative
stress; for example, the early phase response to cleave Aβ includes activating mutations in
APP, PS1, PS2 genes and activating β- and γ-secretases, and the late phase response to activate
the secretases or decrease Aβ clearance includes oxidative stress-related factors (radicals) as
risk factors (i.e., ApoE4, sortilin related receptor 1, clusterin, and complement component)
[41]. It was also reported that the antioxidant and anti-inflammatory drugs GVT (Graft Versus
Tumor) or MSL (monosodium luminol) suppress ts1-induced oxidative stress by up-regulat-
ing the nuclear transcription factor NF-E2-related factor 2 (Nrf2) using a murine retrovirus
ts1 mutant as a model for human immunodeficiency virus (HIV)-associated dementia [42].
Interestingly, an increasing body of evidence supports the notion that Aβ oligomer species
induce cognitive dysfunction that is linked to increased neurogenesis defects, synaptic damage
and inflammation [43]. Moreover, mutations in the APP, PS1 and PS2 genes cause an altered
protein folding process with malfunctions in the endoplasmic reticulum (ER), altered mito-
chondrial function and a decrease in myelin formation associated with cognitive impairments
during the aging process [44].
A natural herbal is viewed as potential alternative countermeasure as AD intervention.
Recent studies include our data indicate that a natural herbal medicines exert in anti-inflam-
matory and anti-AD-like effects in Tg AD mice, and in alleviating the pathological features
that are similar to AD patients. For example, phytochemical compounds with potential anti-
AD-like effects, such as Fulvic acid, prevent the formation of tau filaments [45]. Phenolic com-
pounds (i.e., curcumin, ferulic acid, myricetin, nordihydroguaiaretic acid (NDGA), and ros-
marinic acid (RA), and theaflavins (TF3), the main polyphenolic components found in
fermented black tea, silibinin (silybin), a flavonoid derived from the herb milk thistle (Silybum
marianum)) prevent amyloid plaques, oligomeric fibril formation and affect soluble Aβ species
[46–48] in vitro and in AD model transgenic mice (Tg2576). Moreover, it was shown that nat-
ural compounds, including flavonoids or nutrient supplements contribute to mitigating the
chronic cerebral inflammatory response, which may induce synaptic loss, microglia activation,
and neuronal dysfunction. This is accelerated by the induction of oxidative damage resulting
from the production of misfolded β-amyloid peptide and the formation of the pathological pla-
que and neurofibrillary tangles (NFTs) [49–50].
Longpré et al. [51] reported that the flavonoid fraction could inhibit Aβ-mediated neuro-
toxicity and Aβ fibril formation, which may be due to the activation of the redox-sensitive
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transcription factor NF-KB and the MAPK signaling pathways as a potential mode of action.
In addition, two polyphenol components of pomegranate extract (punicalagin and ellagic
acid) ameliorated the cognitive impairment, which may counteract the microglia activation
and accelerated inflammation associated with the Aβ-induced pro-inflammatory cytokine,
TNF-α, in (APP/PS1) transgenic AD mice [52]. In accord with these data, one of the CG
extract compounds, Maysin has shown insecticidal activity against corn earworm [53], anti-
inflammatory effects by inducting the pro-inflammatory cytokine, TNF-α, and inducible
nitric-oxide synthase (iNOS) gene expression coupled with the phosphorylation of Akt and
MAPK signaling in activated macrophage [54]. Similar to these scientific findings, our results
also indicate that the CG compound could induce the Th2 cytokine response as a result of the
enhanced levels of the anti-inflammatory profile, as shown by IL-4 and IL-10- induction in the
EA-CG (Maysin and its flavonoid derivatives)-treated Tg AD mice after six months of an
EA-CG diet. Furthermore, the brains from the Tg mice were showed a significant reduction in
the amyloid burden, which may be affected by an enhanced anti-inflammatory cytokine
response (Th-2-skewed cytokine response, but partial overlap with the Th1 cellular response)
and anti-oxidant effects to reduce the generation of Aβ42/40 species as well as the humoral
immune response (immunoglobulin IgG response).
Natural flavonoids include CG compound may be bi-functional intervention such as anti-
oxidant and anti-inflammation as an alternative of AD therapeutic tool. However, there are
some existing hurdles to designing better drugs that can answer the question as to whether
intake stability and the persistence of anti-oxidant formulations along with supplements, such
as vitamin E, vitamin C, and beta carotene, may reduce the risk of AD, or whether there is a
need for both anti-oxidant and anti-inflammatory properties to prevent the oxidative stress-
mediated aggregation of Aβ in the AD brain. Moreover, there are some discrepancies in the
AD genetic factors that cause Aβ aggregation (amyloid plaques) or toxic Aβ unfolded mole-
cules in AD patients. Interestingly, it was demonstrated that multiple polyphenol compounds
are beneficial for enhancing cognitive abilities and synergistically mitigating Aβ-mediated neu-
ropathology by reducing the total amyloid content and improving the oligomeric Aβ (oAβ)-
induced long term potentiation (LTP) deficits in hippocampal slices after treatment with a
combination of three polyphenolic preparations (i.e., grape seed extract, resveratrol, and Con-
cord grape juice extract) in J20 AD mice [55].
Limitation of current study due to low yield of byproducts separation in EA-CG does not
validate the difference mode of action of between Maysin (and its flavonoid compounds) and
Luteolin to better understand their beneficial anti-oxidant and anti-inflammatory effects to
BACE as well as cellular immune response focused on T cell biology. It may be accompanied
with the reduced amyloid burden and improved cognitive functions, using behavioral experi-
ments and the recovery of synaptic functions and related brain derived growth factor (BDNF)
include its receptors in cholinergic neurons. We have not yet determined how this dual anti-
AD like functions are associated with prevention of Aβ accumulation or mitigate beta amyloid
plaque in brain due to the low yield of each fraction of chemicals in EA-CG extracts (i.e., May-
sin and its flavonoid derivatives). There are some restrictions to reveal the real aspects of May-
sin’s effectiveness with regard to the inhibition of amyloid plaques in the Tg brains as well as
the amelioration of cognitive impairments using a battery of behavioral experiments in the
future.
In conclusion, we first demonstrated that natural flavoglycoside compounds, such as May-
sin and its precursor phytochemicals that are isolated from CG, profoundly reduce the amyloid
plaque and fibril burden in the hippocampus and cortex using APP/PS1-overexpressing Tg
AD mice. Strength of this study was highlighted such as the beneficiary effect of the EA-CG
fraction (Maysin and its precursor chemicals) such as decrease the soluble Aβ40/42 protein
Anti-Alzheimer Effects of Centipedegrass
PLOS ONE | DOI:10.1371/journal.pone.0169509 January 10, 2017 16 / 20
concentrations in brain lysates, which may be associated with the induction of a Th2-skewed
immune response by producing an immunoglobulin IgG response. Potential activity of the
EA-CG fraction could significantly enhanced the Th2 (anti-inflammatory) cytokine response
compared with Th1 (pro-inflammatory) cytokine response in the serum. With tissue safety
issues during the six months of EA-CG treatment by feeding a mixed diet, there were no haz-
ard symptoms appeared in the hepatic toxicity assay using Tg mice. When natural flavonoid
compounds in EA-CG have proceed their cellular immune response following EA-CG treat-
ment in APP/PS1 Tg mice, we observed that an induction of IFN-γ rather than IL-1α in the
spleen and other organs (data not shown) from the APP/PS1 Tg mice occurs. However, histol-
ogy data did not shown any inflammatory outcomes in APP/PS1 Tg mice fed with these flavo-
noid chemicals for four months. Overall, our results are the first to indicate that the natural
flavonoid compounds in EA-CG extract (i.e., Maysin and its flavonoid derivatives) is a promis-
ing phytochemical therapeutic agents or prophylactic measure, which could prevent amyloid
plaque/Aβ aggregation by enhancing Th2-skewed cytokines rather than Th1 cytokines, partic-
ularly IL-4 and IL-10. This may provide new insights on the role of multiple flavonoids in
effective neuroprotection by enhancing IL-4 and/or IL-10 expression, which would be a
molecular bridge between the anti-oxidant and anti-inflammatory activities. By providing
potential evidences with respect to mitigate amyloid burden and Aβ burden in cerebral and
hippocampus on APP/PS1 tg mice model, it would be permissible to consider Maysin and its
flavonoid compounds in EA-CG as Anti-AD countermeasure. The affect potentially reverse
the cognitive impairments contingent with prevention of BACE and oxidative stress mediated
neuroinflammation by humoral immune response in AD in the future. Further experiments
are required to expedite underlying mechanism in detail by which novel anti-AD, Maysin and
its flavonoid derivatives compounds, counteract cerebral Aβ burden and enhance humeral
and cellular immune network about production of anti-Aβ and anti-inflammatory cytokines
expression and be needed to determine if mitigate cognitive impairment, too.
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